Humans are drawn to self-improvement, and our data-rich world provides ample opportunities to optimise many aspects of life. The biohacking trend applies not only to the body, but also the mind.

Biohacking techniques often involve simply eating specific types of food or trying new exercises. But many are searching for further enhancements with ‘smart drugs’. 

Also known as nootropics, these are various substances that claim to improve the brain’s cognition. Having clear thoughts can lead to better decision making and reduced stress, so it’s no surprise the industry is worth about US$14b

Once associated with students and office workers seeking better focus and productivity, smart drugs are now advertised to help anyone from musicians with their memory and creativity to gamers wanting to improve reaction times.

It’s a wide array of products that includes prescription medications such as Adderall and Ritalin, for those with attention deficit hyperactivity disorder, or over-the-counter supplements like ginkgo biloba. 

Some manufacturers face criticisms about inconsistent regulations and for marketing what can effectively be pricey placebos. These concerns aren’t deterring major companies, with consumer goods giant Unilever ($UL) acquiring supplements firm Onnit in 2021. 

There are also significant efforts towards trying to recapture our childlike ability to absorb new information. The human brain has an estimated 100 billion neurons and we know the number of links between them and the rest of the body declines into adulthood. A multi-billion dollar industry is targeting degenerative diseases like Alzheimer’s, with firms like Eli Lilly ($LLY) and Biogen ($BIIB) bringing new drugs to the market.

Meanwhile, the wellness industry sees personalisation and prevention as central to its future, and smart drugs could play an important role. Customised vitamins are a reality, while there’s ongoing work into tailoring medicine to your DNA. To end where we started, smart drugs might just go full circle and help improve the body as well as the mind.


Want more?

You know what to do

Insights, trends and company deep dives delivered straight to your inbox.

Stake logo
Over 7,000 5-star reviews
App Store logoGoogle Play logo

Subscribe to our free newsletters

By subscribing, you agree to our Privacy Policy.

Stakeshop Pty Ltd, trading as Stake, ACN 610105505, is an authorised representative (Authorised Representative No. 1241398) of Sanlam Private Wealth Pty Ltd (Australian Financial Services Licence No. 337927) ('Sanlam') and an authorised representative (Authorised Representative No. 1241398) of Airwallex Pty Ltd (Australian Financial Services Licence No. 487221) ('Airwallex'). Stake is not authorised by Airwallex under Airwallex’s AFSL to arrange for clients to be issued with securities as Airwallex is not authorised under its AFSL for this purpose. Stake is not authorised by Sanlam under Sanlam’s AFSL to arrange for clients to be issued with a non-cash payment facility as Sanlam is not authorised under its AFSL for this purpose. Stake SMSF Pty Ltd (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. Stakeshop Pty Ltd will also run marketing and promotions to you under. For more information about SMSFs, see our SMSF Risks page.The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. Any advice given by Stake is of a general nature only. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Please view our Financial Services GuideTerms & ConditionsPrivacy Policy and Disclaimers  before deciding to invest on or use Stake or Stake Super. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. Past performance of any product described on this website is not a reliable indication of future performance. Stake and Stake Super are registered trademarks in Australia.

Copyright © 2024 Stake. All rights reserved.